mk-6552
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 20, 2023 (NCT06665230)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tree pollenImmunity, desensitized
Tree pollen immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06567002 | Phase 1 | Sep 9, 2024 | Merck |
| NCT06662396 | Phase 1 | Jun 13, 2024 | Merck |
| NCT06619665 | Phase 1 | Mar 19, 2024 | Merck |
| NCT06179407 | Phase 1 | Jan 9, 2024 | Merck |
| NCT06665230 | Phase 1 | Sep 20, 2023 | Merck |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 5 | 5 | 1 | 2023 |
1 organizations
Page 1 / 1